+111.1%
AXP vs EMR
+63.1%
+48.0%
-28.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.1% | +1.7% | -2.8% | -2.0% |
| 7D | -2.1% | -1.5% | -0.6% | -1.4% |
| 30D | -6.5% | -5.6% | -0.9% | -3.9% |
| 3M | +4.6% | +7.9% | -3.3% | -0.1% |
| 6M | +5.4% | +6.0% | -0.6% | +1.1% |
| YTD | -11.1% | +16.4% | -27.6% | -19.8% |
| 1Y | -0.3% | +16.6% | -16.9% | -10.6% |
| All | +111.1% | +63.1% | +48.0% | +57.2% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling